Free delivery over $100 Learn more

30 days return period Learn more

SKU: 389BIC

Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed)


Blood and Immune Cells & Products > Peripheral Blood Mononuclear Cells (PBMCs)

Product Type: Diseased Human Peripheral Blood Mononuclear Cells

Species: Human

Cell Type: Immune Cells

Source Organ: Blood


Regular price $1,249.00

Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed)

  • Description
    Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed) are isolated from the peripheral blood of newly diagnosed acute myeloid leukemia (AML) patients. The mononuclear cell-rich PBMC layer is separated from diluted whole blood by gradient centrifugation. The cell morphology shows a heterogeneous cell population with a single nucleus, including immature myeloid progenitor cells, monocytes and a small number of lymphocytes.Cytogenetic analysis of these cells commonly reveals chromosomal abnormalities such as t(8;21), inv(16), or monosomy 7, depending on the patient. In in vitro culture, this cell population shows the characteristics of coexistence of adherent growth and suspended growth, and some myeloid progenitor cells can differentiate into leukemic blasts with diverse morphologies These cells typically express CD34, CD33, and HLA-DR, detectable via flow cytometry.They are tumorigenic and can initiate leukemic proliferation when engrafted into immunodeficient mice.
  • Product Name
    Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed)
  • Product Type
    Diseased Human Peripheral Blood Mononuclear Cells
  • Species
    Human
  • Cell Type
    Mononuclear Cell
  • Source Organ
    Peripheral Blood
  • Disease
    Acute Myeloid Leukemia
  • Product Type
    Diseased Human Peripheral Blood Mononuclear Cells
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed) can serve as an in vitro cell model to investigate the pathogenesis of de novo AML and developing novel therapeutic strategies. They also provide a platform for investigating immune evasion mechanisms and developing immunotherapies, such as assessing CAR-T/NK cell cytotoxicity and characterizing immune checkpoint expression patterns.
  • Size/Quantity
    1 vial
  • Quality Control
    All cells test negative for mycoplasma, bacteria, yeast, and fungi.
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.